259200-31-2
Chemical Structure
(2S,3R)-Brassinazole
- CAS No.: 259200-31-2
- Formula:C18H18ClN3O
- Molecular Weight:327.81
IUPAC Name: (2S,3R)-4-(4-chlorophenyl)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)butan-2-ol
InChIKey: YULDTPKHZNKFEY-MSOLQXFVSA-N
SMILES: C[C@](O)(C1=CC=CC=C1)[C@H](N2C=NC=N2)CC3=CC=C(C=C3)Cl
Biological Activity: (2S,3R)-Brassinazole, the enantiomer of Brassinazole (BRZ). Brassinazole inhibits brassinosteroid (BR) biosynthesis, via acting on the oxidative processes from 6-oxo-campestanol to teasterone. (2S,3R)-Brassinazole might be the most active form of Brz[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(2S,3R)-Brassinazole | 98.39% | (2S,3R)-Brassinazole, the enantiomer of Brassinazole (BRZ). Brassinazole inhibits brassinosteroid (BR) biosynthesis, via acting on the oxidative processes from 6-oxo-campestanol to teasterone. (2S,3R)-Brassinazole might be the most active form of Brz. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 1.00
HY-121161(Rac)-Brassinazole -
Similarity Score 1.00
HY-121161ABrassinazole -
Similarity Score 1.00
HY-121161C(2R,3S)-Brassinazole -
Similarity Score 0.68
HY-B0853RPaclobutrazol (Standard) -
Similarity Score 0.68
HY-B0853S(Rac)-Paclobutrazol-15N3 -
Similarity Score 0.68
HY-W329835Fenbuconazole -
Similarity Score 0.63
HY-A0277RCyproconazole (Standard) -
Similarity Score 0.62
HY-135307SSF-109 -
Similarity Score 0.62
HY-113611SDZ89-485 -
Explore the MedChemAI to find more analogs
References
- [1]. Yoshida Shigeo, et al. Preparation of (1,2,4-triazolyl)alkanols as specific inhibitors of brassinosteroid biosynthesis: Japan, JP2000053657. 2000-02-22.
- [2]. Asami T, et al. Mode of action of brassinazole: a specific inhibitor of brassinosteroid biosynthesis[M]. 2000.
- [3]. T Asami, et al. Characterization of Brassinazole, a Triazole-Type Brassinosteroid Biosynthesis Inhibitor. Plant Physiol. 2000 May;123(1):93-100. [Content Brief]